ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,475Medicare Part D Prescriptions Filled, Including Refills
$494K Total Retail Price of All Prescriptions
325 Patients Receiving at Least One Drug in Part D
98%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LEVOTHYROXINE SODIUM 434 434
FUROSEMIDE 334 334
WARFARIN SODIUM 330 306
LISINOPRIL 328 317
AMLODIPINE BESYLATE 327 326
SIMVASTATIN 275 275
GABAPENTIN 254 250
SERTRALINE HCL 191 191
METOPROLOL SUCCINATE 187 187
METOPROLOL TARTRATE 176 170
DONEPEZIL HCL 165 165
MIRTAZAPINE 161 161
HYDROCHLOROTHIAZIDE 160 149
ATORVASTATIN CALCIUM 151 151
OMEPRAZOLE 150 149
CITALOPRAM HBR 138 126
ATENOLOL 130 130
TRAMADOL HCL 130 124
NAMENDA 125 125
ADVAIR DISKUS 114 114
PANTOPRAZOLE SODIUM 110 110
QUETIAPINE FUMARATE 96 96
POTASSIUM CHLORIDE 90 89
METFORMIN HCL 86 86
POLYETHYLENE GLYCOL 3350 85 85
ALLOPURINOL 85 85
CIPROFLOXACIN HCL 85 83
DIOVAN 84 84
LIDODERM 83 83
IPRATROPIUM-ALBUTEROL 78 78
VENLAFAXINE HCL 76 74
RISPERIDONE 75 75
ALENDRONATE SODIUM 74 74
GLIPIZIDE 73 73
ISOSORBIDE MONONITRATE ER 69 69
LOSARTAN POTASSIUM 66 65
CYMBALTA 65 65
PRAVASTATIN SODIUM 64 64
TRAZODONE HCL 62 61
CLOTRIMAZOLE-BETAMETHASONE 56 56
OXYBUTYNIN CHLORIDE ER 56 44
ENALAPRIL MALEATE 55 55
HYDRALAZINE HCL 55 55
ZOLPIDEM TARTRATE 54 53
LANTUS 52 52
NYSTOP 51 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.